NCT07644481
- Conditions
- AML (Acute Myelogenous Leukemia), Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Hematologic Diseases, +6 more
- Locations
-
Not specified
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
3,104 public trials
618 recruiting studies
Leukemia, Myeloid trial results
Not Yet Recruiting
Efficacy of Asciminib in Real-world in Patients With Chronic Myeloid Leukemia in Second or Subsequent Lines
NCT07640750
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
- Locations
-
Not specified
NCT07269470
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
VA-CAG Two-Week vs. Three-Week Regimen for Induction Remission in Newly Diagnosed Acute Myeloid Leukemia.
NCT07642453
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
Not specified
Not Yet Recruiting
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
NCT07575412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Not Yet Recruiting
Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
NCT07634536
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT07623187
- Conditions
- Acute Myeloid Leukaemia, Acute Myeloid Leukaemia (AML), Hematologic Diseases, +6 more
- Locations
-
Not specified
Not Yet Recruiting
ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS
NCT07617363
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Not Yet Recruiting
Phase I Study of FXS0683 in the Treatment of Blood Tumors
NCT07616089
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China
Not Yet Recruiting
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
NCT07607327
- Conditions
- AML (Acute Myelogenous Leukemia), Anemia, Anemia, Refractory, +16 more
- Locations
-
- CareDx, Inc. Brisbane, California, United States